The extension buys time, but the stock remains at risk of delisting if equity falls again. Watch the next 10-Q for stockholders' equity confirmation. Continued ATM sales could pressure the stock further. The thin float and small market cap amplify volatility on any news.
Price Chart
Executive Summary
BioCardia received a Nasdaq extension to October 7, 2026, to regain compliance with the $2.5 million minimum stockholders' equity requirement (Rule 5550(b)(1)). The company raised $4.9 million net through an at-the-market equity offering and believes it now meets the threshold, but Nasdaq will reassess compliance at the next periodic report. Delisting risk is deferred but not eliminated, and the dilutive offering pressures the stock.
Key Facts
- Nasdaq notified BioCardia on April 10, 2026, of stockholders' equity deficiency below $2.5 million.
- Company submitted a compliance plan by May 25, 2026, and on June 9, 2026, Nasdaq granted an extension to October 7, 2026.
- From April 1 to June 5, 2026, BioCardia sold 4,004,330 shares at an average price of $1.27 via its ATM agreement, raising net proceeds of $4.9 million.
- Company believes stockholders' equity now exceeds $2.5 million, but Nasdaq will continue to monitor and may delist if compliance is not sustained at the next periodic report.
Financial Impact
Raised $4.9 million net through ATM offering of 4,004,330 shares at average $1.27 per share; equity cushion improved but dilution significant for a $9M market cap company.
Risk Factors
- Potential delisting if stockholders' equity falls below $2.5 million at the next quarterly report.
- Significant dilution from the ATM offering (4M shares added to likely small float).
- Low market cap ($9M) and limited liquidity amplify downside risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-020384 |
| Document: 0001437749-26-020384-index-headers.html | 0001437749-26-020384 |
| Document: 0001437749-26-020384-index.html | 0001437749-26-020384 |
| Document: 0001437749-26-020384.txt | 0001437749-26-020384 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $0.8975 $1.04 | ▲ +15.88% | ▲ +15.54% | $0.9000 (+0.28%) |
Oct 19, 2026 7d ago | Press Release | $0.9000 $1.04 | ▲ +15.56% | ▲ +15.22% | $0.9000 (−0.00%) |
Oct 7, 2026 19d ago | 8-K | $1.09 $1.06 | ▼ −2.75% | ▼ −2.33% | $0.9000 (−17.43%) |
Oct 1, 2026 25d ago | 8-K | $1.02 $1.04 | ▲ +1.96% | ▲ +1.22% | $0.9000 (−11.76%) |
Oct 1, 2026 25d ago | Press Release | $1.02 $1.04 | ▲ +1.96% | ▲ +1.22% | $0.9000 (−11.76%) |
Sep 23, 2026 4w ago | 8-K | $1.05 $1.07 | ▲ +1.90% | ▲ +1.99% | $0.9000 (−14.29%) |
Sep 23, 2026 4w ago | Press Release | $1.05 $1.07 | ▲ +1.90% | ▲ +1.99% | $0.9000 (−14.29%) |
Sep 10, 2026 6w ago | 8-K | $1.10 $1.08 | ▼ −1.82% | ▼ −2.67% | $0.9000 (−18.18%) |
Aug 24, 2026 9w ago | 8-K | $1.06 $1.13 | ▲ +6.60% | ▲ +6.28% | $0.9000 (−15.09%) |
Aug 5, 2026 11w ago | Press Release | $0.9500 $0.9496 | ▼ −0.04% | ▲ +0.12% | $0.9000 (−5.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers